InvestorsHub Logo
Post# of 252233
Next 10
Followers 68
Posts 4505
Boards Moderated 0
Alias Born 12/13/2009

Re: genisi post# 170484

Monday, 11/25/2013 1:37:26 PM

Monday, November 25, 2013 1:37:26 PM

Post# of 252233
CBST/CXA201 in cUTI: It is actually superior to levofloxacin even though it is a non-inferiority trial, 95% CI = 2.3%, 14.6%.

Result from another ph3 in cIAI will be in late Dec.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.